The stock price of Cardlytics Inc (NASDAQ: CDLX) has dropped by -0.52 compared to previous close of 3.87. Despite this, the company has seen a gain of 9.07% in its stock price over the last five trading days. zacks.com reported 2024-12-17 that Cardlytics (CDLX) made it through our ‘Fast-Paced Momentum at a Bargain’ screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Is It Worth Investing in Cardlytics Inc (NASDAQ: CDLX) Right Now?
Additionally, the 36-month beta value for CDLX is 1.53. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CDLX is 48.45M and currently, short sellers hold a 14.57% ratio of that float. The average trading volume of CDLX on December 27, 2024 was 759.91K shares.
CDLX’s Market Performance
CDLX’s stock has seen a 9.07% increase for the week, with a -4.23% drop in the past month and a 17.02% gain in the past quarter. The volatility ratio for the week is 6.17%, and the volatility levels for the past 30 days are at 7.27% for Cardlytics Inc. The simple moving average for the past 20 days is 0.29% for CDLX’s stock, with a -46.44% simple moving average for the past 200 days.
Analysts’ Opinion of CDLX
Many brokerage firms have already submitted their reports for CDLX stocks, with Evercore ISI repeating the rating for CDLX by listing it as a “In-line.” The predicted price for CDLX in the upcoming period, according to Evercore ISI is $4 based on the research report published on October 11, 2024 of the current year 2024.
Northland Capital, on the other hand, stated in their research note that they expect to see CDLX reach a price target of $5. The rating they have provided for CDLX stocks is “Market Perform” according to the report published on August 16th, 2024.
BofA Securities gave a rating of “Underperform” to CDLX, setting the target price at $3.50 in the report published on August 15th of the current year.
CDLX Trading at -2.36% from the 50-Day Moving Average
After a stumble in the market that brought CDLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -81.24% of loss for the given period.
Volatility was left at 7.27%, however, over the last 30 days, the volatility rate increased by 6.17%, as shares sank -2.28% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.99% upper at present.
During the last 5 trading sessions, CDLX rose by +9.07%, which changed the moving average for the period of 200-days by -55.49% in comparison to the 20-day moving average, which settled at $3.84. In addition, Cardlytics Inc saw -58.20% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CDLX starting from SOSIN CLIFFORD, who sale 19,523 shares at the price of $3.95 back on Dec 03 ’24. After this action, SOSIN CLIFFORD now owns 6,400,210 shares of Cardlytics Inc, valued at $77,174 using the latest closing price.
CAS Investment Partners, LLC, the 10% Owner of Cardlytics Inc, proposed sale 842,898 shares at $4.09 during a trade that took place back on Dec 03 ’24, which means that CAS Investment Partners, LLC is holding shares at $3,447,453 based on the most recent closing price.
Stock Fundamentals for CDLX
Current profitability levels for the company are sitting at:
- -0.66 for the present operating margin
- 0.44 for the gross margin
The net margin for Cardlytics Inc stands at -0.94. The total capital return value is set at -0.8. Equity return is now at value -186.12, with -53.09 for asset returns.
Based on Cardlytics Inc (CDLX), the company’s capital structure generated 0.75 points at debt to capital in total, while cash flow to debt ratio is standing at -0.04. The debt to equity ratio resting at 3.06. The interest coverage ratio of the stock is -23.67.
Currently, EBITDA for the company is -99.0 million with net debt to EBITDA at -0.65. When we switch over and look at the enterprise to sales, we see a ratio of 1.19. The receivables turnover for the company is 2.68for trailing twelve months and the total asset turnover is 0.73. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.18.
Conclusion
In conclusion, Cardlytics Inc (CDLX) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
